PTPRC and neoplasm: Furthermore, we detected an increase in PD‐L1 protein level in the membrane fraction (CD45−/PD‐L1+) in the EDEM3OE tumour compared to control tumours, particularly the tumours after PD‐1 antibody treatment by flow cytometry (Figure 3I and Figure S5A).